JP2023123765A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023123765A5 JP2023123765A5 JP2023108201A JP2023108201A JP2023123765A5 JP 2023123765 A5 JP2023123765 A5 JP 2023123765A5 JP 2023108201 A JP2023108201 A JP 2023108201A JP 2023108201 A JP2023108201 A JP 2023108201A JP 2023123765 A5 JP2023123765 A5 JP 2023123765A5
- Authority
- JP
- Japan
- Prior art keywords
- aav
- nucleic acid
- particles
- polypeptide
- capsid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 claims 33
- 150000007523 nucleic acids Chemical class 0.000 claims 26
- 108020004707 nucleic acids Proteins 0.000 claims 25
- 102000039446 nucleic acids Human genes 0.000 claims 25
- 239000002245 particle Substances 0.000 claims 23
- 210000000234 capsid Anatomy 0.000 claims 13
- 238000000034 method Methods 0.000 claims 12
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 239000013607 AAV vector Substances 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 6
- 241000700605 Viruses Species 0.000 claims 5
- 108091026890 Coding region Proteins 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 238000000338 in vitro Methods 0.000 claims 3
- 108090000565 Capsid Proteins Proteins 0.000 claims 2
- 102100023321 Ceruloplasmin Human genes 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 210000003169 central nervous system Anatomy 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000010415 tropism Effects 0.000 claims 2
- 108020005544 Antisense RNA Proteins 0.000 claims 1
- 108700011259 MicroRNAs Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 108091030071 RNAI Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 210000004436 artificial bacterial chromosome Anatomy 0.000 claims 1
- 210000001106 artificial yeast chromosome Anatomy 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 239000003184 complementary RNA Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000009368 gene silencing by RNA Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000002679 microRNA Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025015920A JP2025072468A (ja) | 2014-11-21 | 2025-02-03 | 中枢神経系を標的化したａａｖベクター |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462082897P | 2014-11-21 | 2014-11-21 | |
| US62/082,897 | 2014-11-21 | ||
| US201562218857P | 2015-09-15 | 2015-09-15 | |
| US62/218,857 | 2015-09-15 | ||
| JP2017525107A JP2017536116A (ja) | 2014-11-21 | 2015-11-20 | 中枢神経系を標的化したａａｖベクター |
| JP2021019477A JP2021097675A (ja) | 2014-11-21 | 2021-02-10 | 中枢神経系を標的化したａａｖベクター |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021019477A Division JP2021097675A (ja) | 2014-11-21 | 2021-02-10 | 中枢神経系を標的化したａａｖベクター |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015920A Division JP2025072468A (ja) | 2014-11-21 | 2025-02-03 | 中枢神経系を標的化したａａｖベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023123765A JP2023123765A (ja) | 2023-09-05 |
| JP2023123765A5 true JP2023123765A5 (Direct) | 2023-11-24 |
Family
ID=56014589
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525107A Withdrawn JP2017536116A (ja) | 2014-11-21 | 2015-11-20 | 中枢神経系を標的化したａａｖベクター |
| JP2021019477A Pending JP2021097675A (ja) | 2014-11-21 | 2021-02-10 | 中枢神経系を標的化したａａｖベクター |
| JP2023108201A Pending JP2023123765A (ja) | 2014-11-21 | 2023-06-30 | 中枢神経系を標的化したａａｖベクター |
| JP2025015920A Pending JP2025072468A (ja) | 2014-11-21 | 2025-02-03 | 中枢神経系を標的化したａａｖベクター |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525107A Withdrawn JP2017536116A (ja) | 2014-11-21 | 2015-11-20 | 中枢神経系を標的化したａａｖベクター |
| JP2021019477A Pending JP2021097675A (ja) | 2014-11-21 | 2021-02-10 | 中枢神経系を標的化したａａｖベクター |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025015920A Pending JP2025072468A (ja) | 2014-11-21 | 2025-02-03 | 中枢神経系を標的化したａａｖベクター |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10532110B2 (Direct) |
| EP (2) | EP4344741A3 (Direct) |
| JP (4) | JP2017536116A (Direct) |
| KR (2) | KR20170086537A (Direct) |
| CN (2) | CN114480440A (Direct) |
| AU (2) | AU2015349759B2 (Direct) |
| BR (1) | BR112017010447A2 (Direct) |
| CA (1) | CA2967393A1 (Direct) |
| IL (1) | IL252072B (Direct) |
| MX (1) | MX2017006652A (Direct) |
| RU (1) | RU2727015C2 (Direct) |
| WO (1) | WO2016081811A1 (Direct) |
Families Citing this family (68)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3151866B1 (en) | 2014-06-09 | 2023-03-08 | Voyager Therapeutics, Inc. | Chimeric capsids |
| SG11201703148TA (en) | 2014-11-05 | 2017-05-30 | Voyager Therapeutics Inc | Aadc polynucleotides for the treatment of parkinson's disease |
| CN107207556B (zh) | 2014-11-14 | 2020-12-08 | 沃雅戈治疗公司 | 调节性多核苷酸 |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| CN114480440A (zh) * | 2014-11-21 | 2022-05-13 | 北卡罗来纳-查佩尔山大学 | 靶向中枢神经系统的aav载体 |
| WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| CA2967468A1 (en) | 2014-12-16 | 2016-06-23 | Board Of Regents Of The University Of Nebraska | Gene therapy for juvenile batten disease |
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| EP3297657B1 (en) | 2015-05-22 | 2020-03-25 | GENKIN, Dmitry Dmitrievich | Extracellular dna as a therapeutic target in neurodegeneration |
| IL292830B2 (en) | 2015-09-28 | 2023-06-01 | Univ Florida | Methods and compositions for stealth virus antibody vectors |
| EP3384035A4 (en) | 2015-12-02 | 2019-08-07 | Voyager Therapeutics, Inc. | ASSAYS FOR THE DETECTION OF AAV-NEUTRALIZING ANTIBODIES |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| IL297576B2 (en) | 2016-05-18 | 2024-02-01 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
| KR102652994B1 (ko) | 2016-05-18 | 2024-04-01 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| CN109415730A (zh) | 2016-06-13 | 2019-03-01 | 北卡罗来纳大学教堂山分校 | 优化的cln1基因和表达盒以及它们的应用 |
| MA44546B1 (fr) | 2016-06-15 | 2021-03-31 | Univ California | Virus adéno-associés variants et procédés d'utilisation |
| EP3500676A4 (en) * | 2016-08-16 | 2020-07-01 | The University of North Carolina at Chapel Hill | METHODS AND COMPOSITIONS FOR TRANSFERRING TARGETED GENES |
| EP3506817A4 (en) | 2016-08-30 | 2020-07-22 | The Regents of The University of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| CN111108198A (zh) | 2017-05-05 | 2020-05-05 | 沃雅戈治疗公司 | 治疗亨廷顿病的组合物和方法 |
| EP3618839A4 (en) | 2017-05-05 | 2021-06-09 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (als) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| AU2018302016A1 (en) | 2017-07-17 | 2020-02-06 | The Regents Of The University Of California | Trajectory array guide system |
| EP3662060A2 (en) | 2017-08-03 | 2020-06-10 | Voyager Therapeutics, Inc. | Compositions and methods for delivery of aav |
| WO2019067840A1 (en) | 2017-09-29 | 2019-04-04 | Voyager Therapeutics, Inc. | RESTRICTING CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE FROM FRIEDREICH ATAXIA BY INTRAVENOUS ADMINISTRATION |
| CA3077426A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| EP4454654A3 (en) | 2017-10-16 | 2025-02-19 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| WO2019094061A1 (en) * | 2017-11-07 | 2019-05-16 | The University Of North Carolina At Chapel Hill | Optimized aga genes and expression cassettes and their use |
| CN111867595A (zh) * | 2017-12-20 | 2020-10-30 | 奥维德医疗公司 | hM4Di在治疗癫痫发作紊乱中的用途 |
| US11905522B2 (en) | 2018-01-16 | 2024-02-20 | Cls Therapeutics Limited | Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity |
| AU2019247746B2 (en) | 2018-04-03 | 2024-08-15 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
| AU2019247748A1 (en) * | 2018-04-03 | 2020-10-08 | Ginkgo Bioworks, Inc. | Antibody-evading virus vectors |
| KR20210006358A (ko) | 2018-04-03 | 2021-01-18 | 스트라이드바이오 인코포레이티드 | 안 조직을 표적으로 하기 위한 바이러스 벡터 |
| CA3099306A1 (en) | 2018-05-15 | 2019-11-21 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of parkinson's disease |
| CN108676097B (zh) * | 2018-05-24 | 2020-01-14 | 北京肽和生物科技有限公司 | 一种靶向肿瘤细胞的嵌合肽或嵌合蛋白及其应用 |
| JP7428664B2 (ja) * | 2018-06-12 | 2024-02-06 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 合成肝臓指向性アデノ随伴ウイルスカプシドおよびその使用 |
| IL279131B2 (en) | 2018-06-28 | 2025-06-01 | Univ North Carolina Chapel Hill | Optimized cln5 genes and expression cassettes and their use |
| IL280300B2 (en) | 2018-08-10 | 2025-06-01 | Univ North Carolina Chapel Hill | Optimized cln7 genes and expression cassettes and their use |
| CA3114199A1 (en) | 2018-09-26 | 2020-04-02 | California Institute Of Technology | Adeno-associated virus compositions for targeted gene therapy |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| CN113166208B (zh) * | 2018-10-02 | 2024-11-22 | 沃雅戈治疗公司 | 重新定向aav衣壳的嗜性 |
| JP2022506066A (ja) | 2018-11-05 | 2022-01-17 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 最適化されたｆｉｇ４遺伝子および発現カセットならびにそれらの使用 |
| WO2020117898A1 (en) * | 2018-12-05 | 2020-06-11 | Abeona Therapeutics Inc. | Recombinant adeno-associated viral vector for gene delivery |
| US12359181B2 (en) | 2018-12-21 | 2025-07-15 | The University Of North Carolina At Chapel Hill | Optimized GALC genes and expression cassettes and their use |
| WO2020223232A1 (en) * | 2019-04-29 | 2020-11-05 | The Trustees Of The University Of Pennsylvania | Novel aav capsids and compositions containing same |
| CA3144654A1 (en) | 2019-04-29 | 2020-11-05 | The University Of North Carolina At Chapel Hill | Optimized sumf1 genes and expression cassettes and their use |
| SG11202112470YA (en) | 2019-05-22 | 2021-12-30 | Univ North Carolina Chapel Hill | Ube3a genes and expression cassettes and their use |
| US20220241394A1 (en) * | 2019-07-12 | 2022-08-04 | Cls Therapeutics Limited | TREATMENT OF DISEASES ASSOCIATED WITH PROTEIN MISFOLDING BY NERVOUS SYSTEM EXPRESSION OF AN ENZYME WHICH HAS A DEOXYRIBONUCLEASE (DNase) ACTIVITY |
| WO2021041489A1 (en) * | 2019-08-29 | 2021-03-04 | The Board Of Trustees Of The Leland Stanford Junior University | Adeno-associated viral vectors for crossing the human blood brain barrier |
| US20220324921A1 (en) * | 2019-09-03 | 2022-10-13 | University Of Cincinnati | Methods and compositions for the treatment of als |
| WO2021076925A1 (en) | 2019-10-17 | 2021-04-22 | Stridebio, Inc. | Adeno-associated viral vectors for treatment of niemann-pick disease type c |
| WO2021167919A1 (en) * | 2020-02-18 | 2021-08-26 | The University Of North Carolina At Chapel Hill | Aav capsid-promoter interactions and cell selective gene expression |
| CA3176506A1 (en) * | 2020-05-01 | 2021-11-04 | The Broad Institute, Inc. | Engineered central nervous system compositions |
| EP4146672A4 (en) * | 2020-05-04 | 2024-10-02 | The University of North Carolina at Chapel Hill | Modified adeno-associated virus vectors that evade neutralizing antibodies and uses thereof |
| CN115916986A (zh) * | 2020-05-05 | 2023-04-04 | 北卡罗来纳大学查佩尔希尔分校 | 修饰的腺相关病毒5衣壳及其用途 |
| CN115806596A (zh) * | 2020-05-22 | 2023-03-17 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 腺相关病毒突变体及其应用 |
| EP4179098A4 (en) | 2020-07-08 | 2024-10-23 | Baylor College Of Medicine | GENE THERAPY FOR STXBP1 ENCEPHALOPATHY |
| CA3184489A1 (en) * | 2020-07-14 | 2022-01-20 | Abeona Therapeutics Inc. | Recombinant adeno-associated viral vectors for multipartite gene delivery |
| US20230159949A1 (en) * | 2020-07-22 | 2023-05-25 | The Broad Institute, Inc. | Engineered muscle targeting compositions |
| WO2022020697A1 (en) | 2020-07-23 | 2022-01-27 | The University Of North Carolina At Chapel Hill | Optimized slc13a5 genes and expression cassettes and their use |
| WO2022034130A1 (en) * | 2020-08-12 | 2022-02-17 | UCB Biopharma SRL | Gene therapy using nucleic acid constructs comprising methyl cpg binding protein 2 (mecp2) promoter sequences |
| IL300717A (en) | 2020-08-19 | 2023-04-01 | Sarepta Therapeutics Inc | ADENO-related virus vectors for the treatment of RETT syndrome |
| CN113563430B (zh) * | 2021-07-30 | 2022-05-31 | 上海信致医药科技有限公司 | 用于治疗眼部疾病的基因递送系统及其应用 |
| JP2024540221A (ja) | 2021-11-02 | 2024-10-31 | ボイジャー セラピューティクス インコーポレイテッド | Ａａｖカプシドバリアント及びその使用 |
| WO2023183304A2 (en) * | 2022-03-21 | 2023-09-28 | Capsigen Inc. | Transcription-dependent directed evolution of aav capsids having enhanced tropism |
| AU2024294136A1 (en) * | 2023-07-20 | 2026-02-05 | Children's Medical Research Institute | Modified cardiotropic aav capsid polypeptides and vectors |
| WO2025084951A1 (en) * | 2023-10-16 | 2025-04-24 | Joint Stock Company "Axelgen" | Recombinant genetic construct, adeno-associated virus for the treatment of metachromatic leukodystrophy |
| WO2025147741A1 (en) * | 2024-01-11 | 2025-07-17 | Children's Medical Research Institute | Aav capsids and vectors for transduction of cells |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474893A (en) | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
| US5023243A (en) | 1981-10-23 | 1991-06-11 | Molecular Biosystems, Inc. | Oligonucleotide therapeutic agent and method of making same |
| US4501729A (en) | 1982-12-13 | 1985-02-26 | Research Corporation | Aerosolized amiloride treatment of retained pulmonary secretions |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| WO1988002026A1 (en) | 1986-09-08 | 1988-03-24 | Applied Biotechnology, Inc. | Empty viral capsid vaccines |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US4968603A (en) | 1986-12-31 | 1990-11-06 | The Regents Of The University Of California | Determination of status in neoplastic disease |
| WO1990005142A1 (en) | 1988-11-10 | 1990-05-17 | Imperial Cancer Research Technology Ltd. | Polypeptides |
| US5916563A (en) | 1988-11-14 | 1999-06-29 | United States Of America | Parvovirus protein presenting capsids |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| US5149797A (en) | 1990-02-15 | 1992-09-22 | The Worcester Foundation For Experimental Biology | Method of site-specific alteration of rna and production of encoded polypeptides |
| ES2026826A6 (es) | 1991-03-26 | 1992-05-01 | Ercros Sa | Procedimiento para la produccion de una vacuna subunidad contra el parvovirus canino y otros virus relacionados. |
| US5478745A (en) | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US5869248A (en) | 1994-03-07 | 1999-02-09 | Yale University | Targeted cleavage of RNA using ribonuclease P targeting and cleavage sequences |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US6204059B1 (en) | 1994-06-30 | 2001-03-20 | University Of Pittsburgh | AAV capsid vehicles for molecular transfer |
| US5599706A (en) | 1994-09-23 | 1997-02-04 | Stinchcomb; Dan T. | Ribozymes targeted to apo(a) mRNA |
| US6040183A (en) | 1995-06-07 | 2000-03-21 | University Of North Carloina At Chapel Hill | Helper virus-free AAV production |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| ES2279531T3 (es) | 1995-12-15 | 2007-08-16 | Intronn, Inc. | Moleculas terapeuticas generadas por corte y empalme en trans. |
| US6083702A (en) | 1995-12-15 | 2000-07-04 | Intronn Holdings Llc | Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| US20030215422A1 (en) | 1996-09-11 | 2003-11-20 | John A. Chiorini | Aav4 vector and uses thereof |
| US6156303A (en) | 1997-06-11 | 2000-12-05 | University Of Washington | Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom |
| CA2329060C (en) | 1998-05-28 | 2011-09-13 | John A. Chiorini | Aav5 vector and uses thereof |
| WO2000017377A2 (en) | 1998-09-22 | 2000-03-30 | University Of Florida | Methods for large-scale production of recombinant aav vectors |
| PT1127150E (pt) | 1998-11-05 | 2007-08-22 | Univ Pennsylvania | ''sequências de ácido nucleico do vírus adeno associado do serotipo 1, vectores e células hospedeiras que as contêm'' |
| AU780231B2 (en) | 1998-11-10 | 2005-03-10 | University Of North Carolina At Chapel Hill, The | Virus vectors and methods of making and administering the same |
| JP2000325085A (ja) | 1999-05-21 | 2000-11-28 | Masafumi Matsuo | デュシェンヌ型筋ジストロフィー治療剤 |
| AU1775901A (en) | 1999-11-17 | 2001-05-30 | Avigen, Inc. | Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| WO2001077350A2 (en) | 2000-04-07 | 2001-10-18 | Large Scale Biology Corporation | Compositions and methods for inhibiting gene expression |
| US6653467B1 (en) | 2000-04-26 | 2003-11-25 | Jcr Pharmaceutical Co., Ltd. | Medicament for treatment of Duchenne muscular dystrophy |
| AU2001268149B2 (en) | 2000-06-01 | 2005-08-18 | University Of North Carolina At Chapel Hill | Methods and compounds for controlled release of recombinant parvovirus vectors |
| ES2256265T3 (es) | 2000-06-01 | 2006-07-16 | University Of North Carolina At Chapel Hill | Vectores de parvovirus duplicados. |
| US6727355B2 (en) | 2000-08-25 | 2004-04-27 | Jcr Pharmaceuticals Co., Ltd. | Pharmaceutical composition for treatment of Duchenne muscular dystrophy |
| US20030083299A1 (en) | 2000-11-04 | 2003-05-01 | Ferguson Ian A. | Non-invasive delivery of polypeptides through the blood-brain barrier |
| US6623729B2 (en) | 2001-07-09 | 2003-09-23 | Korea Advanced Institute Of Science And Technology | Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer |
| ES2526341T3 (es) | 2001-12-17 | 2015-01-09 | The Trustees Of The University Of Pennsylvania | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas |
| ITRM20020253A1 (it) | 2002-05-08 | 2003-11-10 | Univ Roma | Molecole chimeriche di snrna con sequenze antisenso per le giunzioni di splicing del gene della distrofina e applicazioni terapeutiche. |
| US20070026076A1 (en) | 2003-02-24 | 2007-02-01 | Tzyy-Choou Wu | Molecular vaccines employing nucleic acid encoding anti-apoptotic proteins |
| EP2269658B1 (en) | 2003-05-01 | 2018-12-19 | Genzyme Corporation | Gene therapy for neurometabolic disorders |
| US9233131B2 (en) | 2003-06-30 | 2016-01-12 | The Regents Of The University Of California | Mutant adeno-associated virus virions and methods of use thereof |
| CN102212558B (zh) | 2003-09-30 | 2016-08-03 | 宾夕法尼亚大学托管会 | 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用 |
| MXPA06007269A (es) | 2003-12-23 | 2007-07-09 | Univ Pennsylvania | Composiciones y metodos para terapia combinada de enfermedad. |
| FR2874384B1 (fr) | 2004-08-17 | 2010-07-30 | Genethon | Vecteur viral adeno-associe pour realiser du saut d'exons dans un gene codant une proteine a domaines dispensables |
| JP2008537942A (ja) | 2005-03-31 | 2008-10-02 | マイトジェン， インコーポレイテッド | 心疾患のための処置 |
| CN101203613B (zh) | 2005-04-07 | 2012-12-12 | 宾夕法尼亚大学托管会 | 增强腺相关病毒载体功能的方法 |
| WO2007089632A2 (en) * | 2006-01-27 | 2007-08-09 | The University Of North Carolina At Chapel Hill | Heparin and heparan sulfate binding chimeric vectors |
| CN103849629B (zh) * | 2006-06-21 | 2017-06-09 | 尤尼克尔Ip股份有限公司 | 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体 |
| EP2019143A1 (en) | 2007-07-23 | 2009-01-28 | Genethon | CNS gene delivery using peripheral administration of AAV vectors |
| EP2058401A1 (en) | 2007-10-05 | 2009-05-13 | Genethon | Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| US8632764B2 (en) * | 2008-04-30 | 2014-01-21 | University Of North Carolina At Chapel Hill | Directed evolution and in vivo panning of virus vectors |
| US9415121B2 (en) | 2008-12-19 | 2016-08-16 | Nationwide Children's Hospital | Delivery of MECP2 polynucleotide using recombinant AAV9 |
| ES2698203T3 (es) | 2010-04-23 | 2019-02-01 | Univ Massachusetts | Vectores de AAV que se dirigen al SNC y métodos de uso de los mismos |
| US8663624B2 (en) | 2010-10-06 | 2014-03-04 | The Regents Of The University Of California | Adeno-associated virus virions with variant capsid and methods of use thereof |
| US10738326B2 (en) * | 2010-10-27 | 2020-08-11 | Jichi Medical University | Adeno-associated virus vector for gene transfer to nervous system cells |
| KR101830651B1 (ko) | 2011-01-04 | 2018-02-21 | 엘지전자 주식회사 | 정보 표시 장치 및 그 방법 |
| WO2014052789A1 (en) * | 2012-09-28 | 2014-04-03 | The University Of North Carolina At Chapel Hill | Aav vectors targeted to oligodendrocytes |
| CN114480440A (zh) * | 2014-11-21 | 2022-05-13 | 北卡罗来纳-查佩尔山大学 | 靶向中枢神经系统的aav载体 |
-
2015
- 2015-11-20 CN CN202210236316.5A patent/CN114480440A/zh active Pending
- 2015-11-20 WO PCT/US2015/061788 patent/WO2016081811A1/en not_active Ceased
- 2015-11-20 KR KR1020177014680A patent/KR20170086537A/ko not_active Ceased
- 2015-11-20 JP JP2017525107A patent/JP2017536116A/ja not_active Withdrawn
- 2015-11-20 CN CN201580074023.XA patent/CN107532173A/zh active Pending
- 2015-11-20 US US15/525,214 patent/US10532110B2/en active Active
- 2015-11-20 CA CA2967393A patent/CA2967393A1/en active Pending
- 2015-11-20 MX MX2017006652A patent/MX2017006652A/es unknown
- 2015-11-20 EP EP23199459.1A patent/EP4344741A3/en active Pending
- 2015-11-20 KR KR1020247013508A patent/KR20240063169A/ko active Pending
- 2015-11-20 BR BR112017010447-4A patent/BR112017010447A2/pt not_active Application Discontinuation
- 2015-11-20 AU AU2015349759A patent/AU2015349759B2/en active Active
- 2015-11-20 RU RU2017121593A patent/RU2727015C2/ru active
- 2015-11-20 EP EP15861347.1A patent/EP3221453A4/en not_active Ceased
-
2017
- 2017-05-03 IL IL252072A patent/IL252072B/en unknown
-
2019
- 2019-06-13 US US16/440,638 patent/US10561743B2/en active Active
-
2020
- 2020-01-13 US US16/741,324 patent/US11491242B2/en active Active
-
2021
- 2021-02-10 JP JP2021019477A patent/JP2021097675A/ja active Pending
-
2022
- 2022-03-04 AU AU2022201540A patent/AU2022201540B2/en active Active
- 2022-09-21 US US17/933,937 patent/US20230263910A1/en active Pending
-
2023
- 2023-06-30 JP JP2023108201A patent/JP2023123765A/ja active Pending
-
2025
- 2025-02-03 JP JP2025015920A patent/JP2025072468A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023123765A5 (Direct) | ||
| JP2017536116A5 (Direct) | ||
| JP2023076606A5 (Direct) | ||
| JP6093358B2 (ja) | アデノ随伴ウイルスベクターの産生細胞 | |
| JP2022033245A5 (Direct) | ||
| CN111349148A (zh) | 一种腺相关病毒载体及其用途 | |
| CN104937100A (zh) | Aav变体 | |
| JP2024514956A (ja) | 組織標的化された改変ａａｖカプシドおよびその使用方法 | |
| KR20180091863A (ko) | 임상적 사용에 적합한 무혈청 현탁 세포 배양 시스템에서 재조합 아데노-관련 바이러스(aav) 벡터를 생성하기 위한 확장가능한 방법 | |
| CN102947453A (zh) | 用于病毒载体纯化的可扩缩生产平台和用于基因治疗中的如此纯化的病毒载体 | |
| CN111876432B (zh) | 一组肝靶向新型腺相关病毒的获得及其应用 | |
| EP3917566A1 (en) | Methods for using transcription-dependent directed evolution of aav capsids | |
| JPWO2020223236A5 (Direct) | ||
| US12473571B2 (en) | Expression cassette for expressing gene comprising overlapping open reading frames in insect cell and application thereof | |
| CN106916793A (zh) | 一种重组腺相关病毒的制备方法及重组杆状病毒 | |
| JPWO2020223232A5 (Direct) | ||
| AU2021456513B2 (en) | Expression cassette of gene comprising overlapping open reading frames and application thereof in insect cell | |
| JPWO2020223231A5 (Direct) | ||
| CN118420723A (zh) | 提高aav病毒视网膜穿透能力的衣壳蛋白突变体及其应用 | |
| WO2024067153A1 (zh) | 一种用于在昆虫细胞中产生rAAV的核酸、VP1衣壳蛋白突变体及应用 | |
| JPWO2021226008A5 (Direct) | ||
| CN108588097A (zh) | 改造后的hbv基因组和相关组合物及其应用 | |
| CN117003833A (zh) | 肝脏特异性的腺相关病毒血清型及应用 | |
| WO2009125902A1 (en) | Adeno associated virus serotype five vector for targeted gene delivery | |
| CN116970650B (zh) | 一种包膜蛋白组合、含其的靶向病毒载体及制备方法 |